Perfil e financiamento da pesquisa em saúde desencadeada pela pandemia da COVID-19 no Brasil
Perfil e financiamento da pesquisa em saúde desencadeada pela pandemia da COVID-19 no Brasil
Data
2020
Autores
Silva, Rondineli Mendes da
Caetano, Rosângela
Silva, Angélica Baptista
Guedes, Ana Cristina Carneiro Menezes
Ribeiro, Gizele da Rocha
Santos, Daniela Lacerda
Nepomuceno, Carla Cardi
Journal Title
Journal ISSN
Volume Title
Publisher
Vigilância Sanitária em Debate
Resumo
Introdução: O enfrentamento da pandemia COVID-19 desafia o Brasil sobre as medidas a
tomar com a crise sanitária instalada e quais intervenções são mais eficientes e efetivas
frente aos problemas decorrentes da nova doença. Esse quadro de incertezas tem levado
a ações de financiamento de pesquisa em saúde, que visam o aprimoramento científico
e tecnológico, subsidiando a tomada de decisões baseada em evidências. Objetivo:
Mapear as oportunidades de financiamento de pesquisa em saúde para o enfrentamento
da COVID-19 no Brasil, em termos das áreas priorizadas, fontes financiadoras e volumes
financeiros. Método: Fontes públicas foram utilizadas para mapear documentos relativos
ao fomento à pesquisa e à inovação em saúde, junto às instâncias públicas e privadas.
Realizou-se levantamento diretamente nos sítios eletrônicos das instituições públicas
de pesquisa e busca assistemática para identificar financiamentos privados. Os objetos
de financiamentos dos editais e chamadas identificados foram categorizados segundo
grandes áreas e temáticas específicas. Resultados: Foram identificadas 23 oportunidades
de financiamento para o enfrentamento à COVID-19, cobrindo 20 diferentes agentes de
financiamento, totalizando R$ 337.460.612,00. Cinco instâncias públicas responderam
aproximadamente por 75,0% dos recursos. Conclusões: Apesar do pequeno montante
de recursos, houve esforço de fomento à P&D/S em tempo oportuno, principalmente
por parte de órgãos públicos federais, com destaque para CAPES e CNPq. As áreas mais
contempladas foram os insumos necessários ao enfrentamento da COVID-19 (testes
diagnósticos, equipamentos e dispositivos médicos, medicamentos, vacinas e produtos
biológicos) e a tecnologias de telecomunicação e informação. Entretanto, os aportes
atenderam praticamente todas as áreas importantes para o conhecimento, prevenção
e tratamento da doença. Destaca-se que a P&D/S no Brasil tem tido seus recursos
significativamente reduzidos desde 2015.
Introduction: Facing COVID-19 pandemic challenges Brazil on taking actions to deal with the installed health crisis, and to choose which interventions are more efficient and effective with the problems arising from the new disease. This picture of uncertainties has led to health research financing actions, which aim at scientific and technological improvement, supporting evidence-based decision making. Objective: To map the health research funding opportunities to face the COVID-19 in Brazil, in terms of priority areas, funding sources and financial volumes. Methods: We search public sources to map documents related to the promotion of research and innovation in health, with public and private sectors. We conducted a survey directly on the websites of public research institutions and an unsystematic search to identify private financing, and categorized objects of the financing notice and calls identified in large areas and specific topics. Results: We found 23 financing opportunities focusing on the combat of COVID-19 pandemic, covering 20 different financing agents in a total amount of BRL 337,460,612.00. Five public institutions finance 75.0% of the resources. Conclusions: Despite the small amount of resources, there was an effort to promote health R&D in a timely manner, mainly by federal public agencies, with emphasis on CAPES and CNPq. The most contemplated areas were the inputs needed to face COVID-19 (diagnostic tests, medical equipment and devices, medicines, vaccines and biological products) and telecommunication and information technologies. However, the contributions covered practically all the important areas for knowledge, prevention and treatment of the disease. It is noteworthy that health R&D in Brazil has had its resources significantly reduced since 2015.
Introduction: Facing COVID-19 pandemic challenges Brazil on taking actions to deal with the installed health crisis, and to choose which interventions are more efficient and effective with the problems arising from the new disease. This picture of uncertainties has led to health research financing actions, which aim at scientific and technological improvement, supporting evidence-based decision making. Objective: To map the health research funding opportunities to face the COVID-19 in Brazil, in terms of priority areas, funding sources and financial volumes. Methods: We search public sources to map documents related to the promotion of research and innovation in health, with public and private sectors. We conducted a survey directly on the websites of public research institutions and an unsystematic search to identify private financing, and categorized objects of the financing notice and calls identified in large areas and specific topics. Results: We found 23 financing opportunities focusing on the combat of COVID-19 pandemic, covering 20 different financing agents in a total amount of BRL 337,460,612.00. Five public institutions finance 75.0% of the resources. Conclusions: Despite the small amount of resources, there was an effort to promote health R&D in a timely manner, mainly by federal public agencies, with emphasis on CAPES and CNPq. The most contemplated areas were the inputs needed to face COVID-19 (diagnostic tests, medical equipment and devices, medicines, vaccines and biological products) and telecommunication and information technologies. However, the contributions covered practically all the important areas for knowledge, prevention and treatment of the disease. It is noteworthy that health R&D in Brazil has had its resources significantly reduced since 2015.
Description
Palavras-chave
Sistemas de Financiamento da Pesquisa, Política de Pesquisa em Saúde, COVID-19, Epidemia por 2019-nCoV, Pandemias, Research Financing Systems, Health Research Policy, COVID-19, 2019-nCoV Epidemic, Pandemics.
Citação
Silva RM, Caetano M, Silva AB, Guedes ACCM, Ribeiro GR, Santos DL, Nepomuceno CC. Perfil e financiamento da pesquisa em saúde desencadeada pela pandemia da COVID-19 no Brasil [Profile and funding of health research triggered by the COVID-19 pandemic in Brazil]. Vigil. sanit. Debate. 2020 maio;8(2):28-38. doi: 10.22239/2317-269x.01579.